Compare Stocks → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:EMHCVE:IVS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shsIVSInventus MiningC$0.05+11.1%C$0.04C$0.03▼C$0.10C$8.40M0.7688,437 shs87,000 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%IVSInventus Mining0.00%+11.11%+25.00%+66.67%-41.18%One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AIVSInventus MiningN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMHEmerald Health TherapeuticsN/AN/AN/AN/AIVSInventus MiningN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64IVSInventus MiningN/AN/AC$0.00 per share40.00N/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/AIVSInventus Mining-C$1.13MN/AN/A∞N/AN/A-483.41%-106.42%6/14/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AIVSInventus MiningN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMHEmerald Health Therapeutics35.452.972.61IVSInventus Mining76.041.500.07OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMHEmerald Health TherapeuticsN/AIVSInventus MiningN/AInsider OwnershipCompanyInsider OwnershipEMHEmerald Health TherapeuticsN/AIVSInventus Mining39.47%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableIVSInventus MiningN/A167.96 millionN/ANot OptionableHXG, GCM, AQI, EMH, and IVS HeadlinesSourceHeadlineThe Belsey Mark IVmedscape.com - February 23 at 10:23 PMClosing Bell: Inventus Mining Corp down on Wednesday (IVS)theglobeandmail.com - November 8 at 8:57 PMClosing Bell: Inventus Mining Corp down on Monday (IVS)theglobeandmail.com - November 7 at 2:04 AMPower Book IV: Force Season 2 Episode 7tvfanatic.com - October 23 at 2:59 PMInventus Provides Exploration Results from the Dorland Co-Au-Cu-Ni Prospectfinancialpost.com - October 18 at 10:06 AMClosing Bell: Inventus Mining Corp flat on Wednesday (IVS)theglobeandmail.com - October 12 at 5:51 AMClosing Bell: Inventus Mining Corp flat on Monday (IVS)theglobeandmail.com - October 3 at 5:24 AMClosing Bell: Inventus Mining Corp up on Thursday (IVS)theglobeandmail.com - August 25 at 2:58 AMClosing Bell: Inventus Mining Corp up on Monday (IVS)theglobeandmail.com - August 22 at 5:04 PMClosing Bell: Inventus Mining Corp down on Friday (IVS)theglobeandmail.com - August 5 at 6:37 PMClosing Bell: Inventus Mining Corp flat on Friday (IVS)theglobeandmail.com - July 28 at 8:22 PMInventus Completes First Phase of Drilling at the Dorland Prospectfinance.yahoo.com - July 20 at 11:11 AMInventus Mining Completes First Phase of Drilling at Dorland Prospectjuniorminingnetwork.com - July 20 at 11:11 AMNovo Resources: Exploration Update Focused on Discovery Success in 2023juniorminingnetwork.com - July 18 at 12:29 PMINVENTUS Begins Exploration Drilling at Dorland Prospectfinance.yahoo.com - June 28 at 6:23 PMInventus Mining Begins Exploration Drilling at Dorland Prospectjuniorminingnetwork.com - June 28 at 6:23 PMTo Hell and Back: Inside the Tumultuous Making of Diablo IVesquire.com - June 22 at 1:05 AMSony Xperia 1 IVgsmarena.com - June 12 at 7:18 PMUnveiling IVS Crypto 2023 KYOTO, The Largest Crypto Conference in Japaninvezz.com - June 12 at 7:18 PMClosing Bell: Inventus Mining Corp down on Tuesday (IVS)theglobeandmail.com - April 27 at 4:01 PMClosing Bell: Inventus Mining Corp down on Thursday (IVS)theglobeandmail.com - April 21 at 10:05 AMClosing Bell: Inventus Mining Corp up on Tuesday (IVS)theglobeandmail.com - April 20 at 1:06 AMFTSE 350 Mining (FTNMX551030)uk.investing.com - April 7 at 9:37 AMClosing Bell: Inventus Mining Corp flat on Tuesday (IVS)theglobeandmail.com - April 6 at 2:37 PMMedia Sentiment Over TimeCompany DescriptionsEmerald Health TherapeuticsCVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Inventus MiningCVE:IVSInventus Mining Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold and base metals. It holds 100% interests in the Pardo Paleoplacer gold project covering an area of 3.8 square kilometers block of mineral leases and 180 square kilometers of mineral claims; and Sudbury 2.0 project totaling an area of 240 square kilometers of mineral claims located in Sudbury Mining Division, Ontario. The company was formerly known as Ginguro Exploration Inc. and changed its name to Inventus Mining Corp. in April 2015. Inventus Mining Corp. was incorporated in 2005 and is based in Toronto, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.